The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

被引:1
|
作者
Zhang, Meilan [1 ]
Zheng, Zhaokuan [2 ]
Wang, Shouliang [3 ]
Liu, Ruihan [3 ]
Zhang, Mengli [3 ]
Guo, Zhiyun [1 ]
Wang, Hao [1 ]
Tan, Weige [3 ]
机构
[1] Guangzhou Med Univ, Affiliated Panyu Cent Hosp, Guangzhou 511400, Guangdong, Peoples R China
[2] Southern Med Univ, Affiliated Huadu Hosp, Peoples Hosp HuaduDist, Dept Orthoped, Guangzhou 510810, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, 151 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China
关键词
miRNAs; circRNAs; breast cancer; clinical values; PROMOTES TRASTUZUMAB-RESISTANCE; TAMOXIFEN RESISTANCE; MESSENGER-RNA; METASTASIS; BIOGENESIS; CHEMORESISTANCE; PROLIFERATION; ADRIAMYCIN; MECHANISMS; BIOMARKERS;
D O I
10.20517/cdr.2024.62
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are small non-coding RNAs comprising 19-24 nucleotides that indirectly control gene expression. In contrast to other non-coding RNAs (ncRNAs), circular RNAs (circRNAs) are defined by their covalently closed loops, forming covalent bonds between the 3' and 5' ends. circRNAs regulate gene expression by interacting with miRNAs at transcriptional or post-transcriptional levels. Accordingly, circRNAs and miRNAs control many biological events related to cancer, including cell proliferation, metabolism, cell cycle, and apoptosis. Both circRNAs and miRNAs are involved in the pathogenesis of diseases, such as breast cancer. This review focuses on the latest discoveries on dysregulated circRNAs and miRNAs related to breast cancer, highlighting their potential as biomarkers for clinical diagnosis, prognosis, and chemotherapy response.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] circRNAs in drug resistance of breast cancer
    Misir, Sema
    Yaman, Serap Ozer
    Petrovic, Nina
    Sumer, Ceren
    Hepokur, Ceylan
    Aliyazicioglu, Yuksel
    ONCOLOGY RESEARCH, 2022, 30 (04) : 157 - 172
  • [2] Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
    Kinnel, Briana
    Singh, Santosh Kumar
    Oprea-Ilies, Gabriela
    Singh, Rajesh
    CANCERS, 2023, 15 (04)
  • [3] Functional miRNAs in breast cancer drug resistance
    Hu, Weizi
    Tan, Chunli
    He, Yunjie
    Zhang, Guangqin
    Xu, Yong
    Tang, Jinhai
    ONCOTARGETS AND THERAPY, 2018, 11 : 1529 - 1541
  • [4] The role of circRNAs in regulation of drug resistance in ovarian cancer
    Zhan, Jun
    Li, Zhiyi
    Lin, Changsheng
    Wang, Dingding
    Yu, Lei
    Xiao, Xue
    FRONTIERS IN GENETICS, 2023, 14
  • [5] Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy
    Lu, Ling
    Gao, Zihan
    Jin, Longtao
    Geng, Hao
    Liang, Zhaofeng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] The role of miRNAs in tamoxifen resistance in breast cancer
    Healy, N. A.
    Schiff, R.
    Miller, N.
    Osborne, C. K.
    Kerin, M. J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 8 - 8
  • [7] Autophagy-related miRNAs, exosomal miRNAs, and circRNAs in tumor progression and drug-and radiation resistance in colorectal cancer
    Jia, Liting
    Meng, Qingyun
    Xu, Xiaofeng
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 263
  • [8] Gastrointestinal cancer drug resistance: the role of exosomal miRNAs
    Mahsa Salehi
    Asma Vafadar
    Seyyed Hossein Khatami
    Mortaza Taheri-Anganeh
    Omid Vakili
    Amir Savardashtaki
    Babak Negahdari
    Parisa Naeli
    Hamid Behrouj
    Hassan Ghasemi
    Ahmad Movahedpour
    Molecular Biology Reports, 2022, 49 : 2421 - 2432
  • [9] Gastrointestinal cancer drug resistance: the role of exosomal miRNAs
    Salehi, Mahsa
    Vafadar, Asma
    Khatami, Seyyed Hossein
    Taheri-Anganeh, Mortaza
    Vakili, Omid
    Savardashtaki, Amir
    Negahdari, Babak
    Naeli, Parisa
    Behrouj, Hamid
    Ghasemi, Hassan
    Movahedpour, Ahmad
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2421 - 2432
  • [10] Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
    Riquelme, Ismael
    Letelier, Pablo
    Riffo-Campos, Angela L.
    Brebi, Priscilla
    Carlos Roa, Juan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03):